Shalina Ousman

Shalina S. Ousman

Ph.D.

Positions

Associate Professor

Cumming School of Medicine, Department of Clinical Neurosciences

Full Member

Hotchkiss Brain Institute

Full Member

The Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases

Affiliations

Associate Professor

Cumming School of Medicine, Department of Cell Biology and Anatomy

Contact information

Web presence

Phone number

Office: +1 (403) 210-6231

I'm looking for...

Learning opportunities

Positions available:

https://cumming.ucalgary.ca/labs/neuroimmunology/opportunities

Background

Educational Background

B.Sc.H. Biology, Queen's University, 1993

M.Sc. Physiology, Queen's University, 1995

Ph.D. Neuroscience, McGill University, 2001

PDF Neuropharmacology, The Scripps Research Institute, 2001

PDF Neurology and Neurological Sciences, Stanford University, 2008

Biography

Dr. Shalina Ousman is an Associate Professor in the Departments of Clinical Neurosciences and, Cell Biology & Anatomy at the Hotchkiss Brain Institute, University of Calgary. Dr. Ousman completed her PhD in Neurosciences in 2001 with Dr. Samuel David at McGill University followed by two postdoctoral fellowships, the first with Dr. Iain Campbell in the Department of Neuropharmacology at The Scripps Research Institute (2001-2004) and the second with Dr. Lawrence Steinman in the Department of Neurology and Neurological Sciences at Stanford University (2007-2008). She joined the Hotchkiss Brain Institute at the University if Calgary as an Assistant Professor in 2008 where she is a member of the Hotchkiss Brain Institute Multiple Sclerosis NeuroTeam as well as the Spinal Cord, Nerve Injury and Pain NeuroTeam. Dr. Ousman is interested in identifying endogenous protective mechanisms in multiple sclerosis and peripheral nerve regeneration. Her research is funded by the Canadian Institute of Health Research and MS Canada.

Research

Areas of Research

Activities

Identification of endogenous protective molecules and mechanisms in multiple sclerosis and peripheral nerve regeneration.

Participation in university strategic initiatives

Courses

Course number Course title Semester
MDSC 755 Lab/Lec 20/03 Neuroimmunology Spring 2022

Awards

  • Graduate Program Education Award , Hotchkiss Brain Institute . 2018
  • Peak Scholar in Entrepreneurship, Innovation & Knowledge Engagement, University of Calgary. 2017
  • Profiled Researcher, Department of Clinical Neurosciences, University of Calgary . 2017
  • Immigrant Women of Inspiration, Canadian Immigrant Magazine. 2016
  • Graduate Program Education Award , Hotchkiss Brain Institute . 2014
  • Profiled Researcher, Report to the Community, Hotchkiss Brain Institute . 2014
  • Profiled Researcher, Department of Clinical Neurosciences, University of Calgary . 2013
  • Profiled Researcher, Research Calendar, Alberta Innovates-Health Solutions . 2011
  • Calgary’s Top 40 Under 40, Avenue Magazine. 2011
  • AHFMR Scholar, Alberta Innovates. 2009
  • Dr. Donald Paty Career Development Award, Multiple Sclerosis Society of Canada . 2009
  • Profiled Researcher, Research News, Alberta Innovates-Health Solutions . 2009
  • Doctoral Research Studentship, Multiple Sclerosis Society of Canada . 2007
  • Post-doctoral Fellowship, Multiple Sclerosis Society of Canada . 2003
  • Post-doctoral Fellowship, National Multiple Sclerosis Society . 2002
  • Cumming School of Medicine's van de Sande Distinguished Achievement Award, University of Calgary. 2023
  • University of Calgary Research Excellence Chair, University of Calgary. 2024

More Information

I am looking for graduate students and post-doctoral fellows who have a love for science, are creative and logical, have strong problem solving abilities, are enthusiastic, diligent, detail oriented, self-motivated/highly self driven and independent, with a high level of perseverance, strong work ethics and high ethical standards. You will work with a vibrant, hard working group of individuals whose goal is to make a positive impact on humankind whether it be through the knowledge we create or potential therapeutics we discover.